114 related articles for article (PubMed ID: 11606140)
21. Plasmin-activated prodrugs for cancer chemotherapy. 2. Synthesis and biological activity of peptidyl derivatives of doxorubicin.
Chakravarty PK; Carl PL; Weber MJ; Katzenellenbogen JA
J Med Chem; 1983 May; 26(5):638-44. PubMed ID: 6302253
[TBL] [Abstract][Full Text] [Related]
22. Design and synthesis of a pro-drug of vinblastine targeted at treatment of prostate cancer with enhanced efficacy and reduced systemic toxicity.
Brady SF; Pawluczyk JM; Lumma PK; Feng DM; Wai JM; Jones R; DeFeo-Jones D; Wong BK; Miller-Stein C; Lin JH; Oliff A; Freidinger RM; Garsky VM
J Med Chem; 2002 Oct; 45(21):4706-15. PubMed ID: 12361397
[TBL] [Abstract][Full Text] [Related]
23. Characterization of a novel prostate-specific antigen-activated peptide-doxorubicin conjugate in patients with prostate cancer.
DiPaola RS; Rinehart J; Nemunaitis J; Ebbinghaus S; Rubin E; Capanna T; Ciardella M; Doyle-Lindrud S; Goodwin S; Fontaine M; Adams N; Williams A; Schwartz M; Winchell G; Wickersham K; Deutsch P; Yao SL
J Clin Oncol; 2002 Apr; 20(7):1874-9. PubMed ID: 11919247
[TBL] [Abstract][Full Text] [Related]
24. Elongated multiple electronic cascade and cyclization spacer systems in activatible anticancer prodrugs for enhanced drug release.
de Groot FM; Loos WJ; Koekkoek R; van Berkom LW; Busscher GF; Seelen AE; Albrecht C; de Bruijn P; Scheeren HW
J Org Chem; 2001 Dec; 66(26):8815-30. PubMed ID: 11749612
[TBL] [Abstract][Full Text] [Related]
25.
Cornillie J; Wozniak A; Pokreisz P; Casazza A; Vreys L; Wellens J; Vanleeuw U; Gebreyohannes YK; Debiec-Rychter M; Sciot R; Hompes D; Schöffski P
Mol Cancer Ther; 2017 Aug; 16(8):1566-1575. PubMed ID: 28566438
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and biological evaluation of 2'-carbamate-linked and 2'-carbonate-linked prodrugs of paclitaxel: selective activation by the tumor-associated protease plasmin.
de Groot FM; van Berkom LW; Scheeren HW
J Med Chem; 2000 Aug; 43(16):3093-102. PubMed ID: 10956217
[TBL] [Abstract][Full Text] [Related]
27. Direct Real-Time Monitoring of Prodrug Activation by Chemiluminescence.
Gnaim S; Scomparin A; Das S; Blau R; Satchi-Fainaro R; Shabat D
Angew Chem Int Ed Engl; 2018 Jul; 57(29):9033-9037. PubMed ID: 29786931
[TBL] [Abstract][Full Text] [Related]
28. Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents.
Hu Z; Jiang X; Albright CF; Graciani N; Yue E; Zhang M; Zhang SY; Bruckner R; Diamond M; Dowling R; Rafalski M; Yeleswaram S; Trainor GL; Seitz SP; Han W
Bioorg Med Chem Lett; 2010 Feb; 20(3):853-6. PubMed ID: 20060717
[TBL] [Abstract][Full Text] [Related]
29. The anti-tumour effects of the prodrugs N-l-leucyl-doxorubicin and vinblastine-isoleucinate in human ovarian cancer xenografts.
Boven E; Hendriks HR; Erkelens CA; Pinedo HM
Br J Cancer; 1992 Dec; 66(6):1044-7. PubMed ID: 1457343
[TBL] [Abstract][Full Text] [Related]
30. Doxazolidine, a proposed active metabolite of doxorubicin that cross-links DNA.
Post GC; Barthel BL; Burkhart DJ; Hagadorn JR; Koch TH
J Med Chem; 2005 Dec; 48(24):7648-57. PubMed ID: 16302805
[TBL] [Abstract][Full Text] [Related]
31. Targeting cell-impermeable prodrug activation to tumor microenvironment eradicates multiple drug-resistant neoplasms.
Wu W; Luo Y; Sun C; Liu Y; Kuo P; Varga J; Xiang R; Reisfeld R; Janda KD; Edgington TS; Liu C
Cancer Res; 2006 Jan; 66(2):970-80. PubMed ID: 16424032
[TBL] [Abstract][Full Text] [Related]
32. Cephalosporin derivatives of doxorubicin as prodrugs for activation by monoclonal antibody-beta-lactamase conjugates.
Vrudhula VM; Svensson HP; Senter PD
J Med Chem; 1995 Apr; 38(8):1380-5. PubMed ID: 7731023
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis, and preliminary evaluation of doxazolidine carbamates as prodrugs activated by carboxylesterases.
Burkhart DJ; Barthel BL; Post GC; Kalet BT; Nafie JW; Shoemaker RK; Koch TH
J Med Chem; 2006 Nov; 49(24):7002-12. PubMed ID: 17125253
[TBL] [Abstract][Full Text] [Related]
34. A novel macromolecular prodrug concept exploiting endogenous serum albumin as a drug carrier for cancer chemotherapy.
Kratz F; Müller-Driver R; Hofmann I; Drevs J; Unger C
J Med Chem; 2000 Apr; 43(7):1253-6. PubMed ID: 10753462
[No Abstract] [Full Text] [Related]
35. Development and in vitro efficacy of novel MMP2 and MMP9 specific doxorubicin albumin conjugates.
Kratz F; Drevs J; Bing G; Stockmar C; Scheuermann K; Lazar P; Unger C
Bioorg Med Chem Lett; 2001 Aug; 11(15):2001-6. PubMed ID: 11454467
[TBL] [Abstract][Full Text] [Related]
36. Novel peptide-doxorubucin conjugates for targeting breast cancer cells including the multidrug resistant cells.
Soudy R; Chen C; Kaur K
J Med Chem; 2013 Oct; 56(19):7564-73. PubMed ID: 24028446
[TBL] [Abstract][Full Text] [Related]
37. Preclinical toxicity, toxicokinetics, and antitumoral efficacy studies of DTS-201, a tumor-selective peptidic prodrug of doxorubicin.
Ravel D; Dubois V; Quinonero J; Meyer-Losic F; Delord J; Rochaix P; Nicolazzi C; Ribes F; Mazerolles C; Assouly E; Vialatte K; Hor I; Kearsey J; Trouet A
Clin Cancer Res; 2008 Feb; 14(4):1258-65. PubMed ID: 18281561
[TBL] [Abstract][Full Text] [Related]
38. Development of albumin-binding doxorubicin prodrugs that are cleaved by prostate-specific antigen.
Kratz F; Mansour A; Soltau J; Warnecke A; Fichtner I; Unger C; Drevs J
Arch Pharm (Weinheim); 2005 Oct; 338(10):462-72. PubMed ID: 16211657
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of combination therapy schedules of doxorubicin and an acid-sensitive albumin-binding prodrug of doxorubicin in the MIA PaCa-2 pancreatic xenograft model.
Kratz F; Azab S; Zeisig R; Fichtner I; Warnecke A
Int J Pharm; 2013 Jan; 441(1-2):499-506. PubMed ID: 23149257
[TBL] [Abstract][Full Text] [Related]
40. Application of the ADEPT strategy to the MDR resistance in cancer chemotherapy.
Desbene S; Van HD; Michel S; Tillequin F; Koch M; Schmidt F; Florent JC; Monneret C; Straub R; Czech J; Gerken M; Bosslet K
Anticancer Drug Des; 1999 Apr; 14(2):93-106. PubMed ID: 10405636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
